催眠疗法对抑郁症患者及其家庭的影响

摘要

Objective To investigate the influence of hypnotherapy in patients with depression and their families. Methods One hundred and thirty-six cases of hospitalization or outpatient patients with depression were divided into the study group and the control group according to the order. The study group and the control group were treated with hypnosis therapy and venlafaxine, respectively. All patients were observed for 6 weeks. Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale (HAMD) were assessed for patients with depression and the Symptom Checklist (SCL-90) and family assessment table (FAD) were assessed for thir families in the 0 and 6 weeks. Results There were no significant differences between the two groups in the clinical efficacy (χ2=1.31,> 0.05) and the HAMD, HAMA scores in the 0 and 6 weeks ( >0.05) . There were significant differences between the 0 and 6 weeks within the two groups in the HAMD and HAMA scores ( < 0.05). There was no significant difference between the family members of two groups in the SCL-90 factor scores in the 0 and 6 weeks (>0.05) . There was no significant difference between the two groups in the FAD factor scores in the 0 and 6 weeks. There was significant difference between the 0 and 6 weeks within the two groups with emotional involvement, communication and FAD total scores ( <0.05). There were positiue correlations between the HAMA factor scores and FAD total scores ( <0.05) and between the HAMD factor scores and emotional involvement scores ( <0.05) . Conclusion There was equivalent efficacy between hypnotherapy and antidepressants in patients with depression. Hypnotherapy can effectively make the patient's depression and anxiety better and improve their family functions.%目的：探讨催眠疗法对抑郁症患者及其家庭的影响．方法选择136例住院或门诊治疗的抑郁症患者，按照入组顺序分为研究组和对照组．研究组采用催眠疗法，对照组采用常规抗抑郁药文拉法辛．对2组患者观察6周，第0、6周时作汉密尔顿焦虑量表(HAMA)、汉密尔顿抑郁量表（HAMD），对其家人作症状自评量表(SCL-90)、家庭功能评定量表(FAD)评分．结果2组间临床疗效差异无统计学意义（＞0.05）；治疗前后，2组间比较HAMD、HAMA评分差异均无统计学意义（＞0.05），组内比较，两组HAMD、HAMA评分差异均有统计学意义（＜0.05）；2组家庭成员SCL-90各因子分差异均无统计学意义（＞0.05）；2组间比较，第0、6周FAD各因子分差异均无统计学意义（＞0.05），组内比较，情感介入、沟通和总分差异均有统计学意义（＜0.05）；HAMA因子分与家庭总功能成正相关关系（＜0.05）；HAMD因子分与情感介入成正相关关系（＜0.05）．结论催眠疗法与抗抑郁药疗效相当，可以有效改善患者的抑郁、焦虑情绪及其家庭功能．